Waldencast plc (WALD) H1 Revenue Falls 57%; Plans Nasdaq Delisting
Waldencast plc reported H1 2026 Milk Makeup net revenue of $26.1M, down 57% YoY, and Adjusted EBITDA of -$14.8M. It completed the sale of Obagi Medical for up to $460M, repaid $178.4M debt, recorded a $52.3M goodwill impairment, and plans to delist from Nasdaq.Material DetailsContext by AI AnalystT…